"The U.S. Food and Drug Administration today approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.
Sivextro is approved to treat patients with acute bacterial skin and skin structure infecti"...
- Patient Information:
Details with Side Effects
DERMATOP Ointment (prednicarbate ointment) 0.1% is a medium potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
DOSAGE AND ADMINISTRATION
Apply a thin film of DERMATOP Ointment (prednicarbate ointment) 0.1% to the affected skin areas twice daily. Rub in gently.
DERMATOP Ointment (prednicarbate ointment) 0.1% is supplied in 15 gram (NDC 0066-0508-15) and 60 gram (NDC 0066-0508-60) tubes.
Store at controlled room temperature (59 to 86°F or 15 to 30°C).
Dermik Laboratories a business of sanofi-aventis U.S. LLC Bridgewater, NJ 08807. Revised November 2010
Last reviewed on RxList: 1/20/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional Dermatop Ointment Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.